Pilot Study on HEMO-INTEGRA for Intraoperative Hemodynamic Monitoring in Cardiac Surgery
The HEMO-INTEGRA system integrates multiple hemodynamic monitoring domains into a single dashboard during cardiac surgery.
Phase III
Cardiology / Intraoperative Monitoring
Status
Active
Sponsor
HEMO-INTEGRA
Signal Score
8.2
Signal assessment
Signal strength
high
Confidence level
moderate
Why it matters
The HEMO-INTEGRA pilot study represents a potential shift in intraoperative monitoring practices within cardiac surgery. If successful, it could set a new standard of care, influencing both clinical outcomes and competitive dynamics in the market.
Recommended action
Humanexa recommends Monitor.
Analysis
Monitor results of the pilot study for feasibility and data capture effectiveness, as well as any subsequent trials or regulatory developments.
Related companies & assets
Companies
Assets
Sources & Humanexa intelligence
Related signals
Newsletter
Get signals before the market moves
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.